CMR Surgical Secures Over $200M for Global Expansion

CMR Surgical has secured over $200 million in a financing round to accelerate the global expansion of its Versius Surgical Robotic System, particularly targeting the U.S. market. The funding, which combines equity and debt capital, was supported by existing investors and new participant Trinity Capital, announced in a press release.

The funds will be used to enhance the commercial reach of Versius, which is the second most adopted soft tissue surgical robot worldwide, having been used in over 30,000 procedures across more than 30 countries. The company aims to continue advancing surgical robotics innovation and product development, including the launch of the newly enhanced Versius Plus.

CMR Surgical's CEO, Massimiliano Colella, emphasized the company's readiness to capitalize on significant market opportunities, especially in the U.S., while deepening its presence in existing markets. The company is also conducting clinical trials to expand the applications of Versius, including a pioneering study in pediatric surgery and a transoral robotic surgery trial.